Status:
UNKNOWN
Immunotherapy for Elderly Patients With Chronic Osteoporotic Pain
Lead Sponsor:
RenJi Hospital
Conditions:
Osteoporotic Pain
Eligibility:
All Genders
60-80 years
Phase:
PHASE4
Brief Summary
Osteoporotic pain is the most common clinical symptom in elderly patients. The course of pain is prolonged and the effect of clinical treatment is limited. This study will observe the therapeutic effe...
Detailed Description
About 70% of the elderly patients suffered osteoporotic pain, mainly involving the limbs and low back. The pain prolonged and varies from mild to severe, and the effect of the clinical treatment is po...
Eligibility Criteria
Inclusion
- Patients suffered osteoporotic pain diagnosed by specialists
- VAS scores greater than 5
- Normal reading and understanding ability
- Communicate normally
- Volunteer to participate
Exclusion
- Mental illness
- Serious physical disease
- Unwilling to cooperate
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04524169
Start Date
November 1 2020
End Date
December 31 2021
Last Update
August 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diansan Su
Shanghai, Shanghai Municipality, China, 200127